Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
Argus Health
Citi
Moodys
Cipla
UBS
Federal Trade Commission
US Army
Mallinckrodt

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 079054

« Back to Dashboard

NDA 079054 describes ALFUZOSIN HYDROCHLORIDE, which is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Mylan, Sun Pharma Global, Teva Pharms, Torrent Pharms, Unichem Labs Ltd, and Wockhardt Ltd, and is included in nine NDAs. It is available from nineteen suppliers. Additional details are available on the ALFUZOSIN HYDROCHLORIDE profile page.

The generic ingredient in ALFUZOSIN HYDROCHLORIDE is alfuzosin hydrochloride. There are nineteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the alfuzosin hydrochloride profile page.
Summary for 079054
Tradename:ALFUZOSIN HYDROCHLORIDE
Applicant:Torrent Pharms
Ingredient:alfuzosin hydrochloride
Patents:0
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 079054
Mechanism of ActionAdrenergic alpha-Antagonists
Suppliers and Packaging for NDA: 079054
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079054 ANDA Torrent Pharmaceuticals Limited 13668-021 N 13668-021-01
ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079054 ANDA Torrent Pharmaceuticals Limited 13668-021 N 13668-021-64

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength10MG
Approval Date:Jul 18, 2011TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Chubb
Queensland Health
Federal Trade Commission
Moodys
Accenture
Colorcon
AstraZeneca
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot